Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/08/19 → 24/10/23 |
A Phase III, Multicenter, Randomized, Open-Label Study Comparing Atezolizumab (Anti-PD-L1 Antibody) in combination with adjuvant Anthracycline/Taxane-based Chemotherapy versus Chemotherapy Alone in patients with operable Triple-Negative Breast Cancer
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Kefford, Richard (Chief Investigator)
- Chapman, Nicola (Research Coordinator)
- Butala, Radhika (Research Coordinator)
Project: Other